share_log

XORTX Therapeutics Inc: ON FORM 13-502F3A (CLASS 3A REPORTING ISSUERS -PARTICIPATION FEE)

SEDAR ·  Feb 27, 2017 14:32
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more